 | • レポートコード：D005-00384 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、外分泌膵機能不全の世界市場を広く調査・分析し、今後の市場展望をまとめております。外分泌膵機能不全の種類別市場規模（栄養管理、膵酵素補充療法（PERT）、生活習慣改善アプローチ）、用途別市場規模（磁気共鳴画像法（MRI）、CTスキャン、超音波内視鏡検査（EUS）、血液検査、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Axcan Pharma、Cilian、Aptalis Pharma、Eli Lilly、Laboratoires Mayoly Spindler、Nordmark Arzneimittel ・地域別グローバル市場分析 2015年-2020年 ・外分泌膵機能不全の北米市場（アメリカ、カナダ、メキシコ） ・外分泌膵機能不全のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・外分泌膵機能不全のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・外分泌膵機能不全の南米市場（ブラジル、アルゼンチン） ・外分泌膵機能不全の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：栄養管理、膵酵素補充療法（PERT）、生活習慣改善アプローチ ・用途別分析：磁気共鳴画像法（MRI）、CTスキャン、超音波内視鏡検査（EUS）、血液検査、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Exocrine Pancreatic Insufficiency market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 2402.2 million by 2025, from USD 2073.7 million in 2019.
The Exocrine Pancreatic Insufficiency market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Exocrine Pancreatic Insufficiency market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Exocrine Pancreatic Insufficiency market has been segmented into:
Nutritional management
Pancreatic enzyme replacement therapy (PERT)
Life style modifications approach
By Application, Exocrine Pancreatic Insufficiency has been segmented into:
Magnetic resonance imaging (MRI)
CT scanning
Endoscopic ultrasonography (EUS)
Blood tests
Other tests
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Exocrine Pancreatic Insufficiency market presented in the report. This section sheds light on the sales growth of different regional and country-level Exocrine Pancreatic Insufficiency markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Exocrine Pancreatic Insufficiency market.
The report offers in-depth assessment of the growth and other aspects of the Exocrine Pancreatic Insufficiency market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Exocrine Pancreatic Insufficiency Market Share Analysis
Exocrine Pancreatic Insufficiency competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Exocrine Pancreatic Insufficiency sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Exocrine Pancreatic Insufficiency sales, revenue and market share for each player covered in this report.
The major players covered in Exocrine Pancreatic Insufficiency are:
Axcan Pharma
Cilian
Aptalis Pharma
Eli Lilly
Laboratoires Mayoly Spindler
Nordmark Arzneimittel
Table of Contents
1 Exocrine Pancreatic Insufficiency Market Overview
1.1 Product Overview and Scope of Exocrine Pancreatic Insufficiency
1.2 Classification of Exocrine Pancreatic Insufficiency by Type
1.2.1 Global Exocrine Pancreatic Insufficiency Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Type in 2019
1.2.3 Nutritional management
1.2.4 Pancreatic enzyme replacement therapy (PERT)
1.2.5 Life style modifications approach
1.3 Global Exocrine Pancreatic Insufficiency Market by Application
1.3.1 Overview: Global Exocrine Pancreatic Insufficiency Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Magnetic resonance imaging (MRI)
1.3.3 CT scanning
1.3.4 Endoscopic ultrasonography (EUS)
1.3.5 Blood tests
1.3.6 Other tests
1.4 Global Exocrine Pancreatic Insufficiency Market by Regions
1.4.1 Global Exocrine Pancreatic Insufficiency Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Exocrine Pancreatic Insufficiency (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Exocrine Pancreatic Insufficiency Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Exocrine Pancreatic Insufficiency Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Exocrine Pancreatic Insufficiency Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Exocrine Pancreatic Insufficiency Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Exocrine Pancreatic Insufficiency Status and Prospect (2015-2025)
2 Company Profiles
2.1 Axcan Pharma
2.1.1 Axcan Pharma Details
2.1.2 Axcan Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Axcan Pharma SWOT Analysis
2.1.4 Axcan Pharma Product and Services
2.1.5 Axcan Pharma Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cilian
2.2.1 Cilian Details
2.2.2 Cilian Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cilian SWOT Analysis
2.2.4 Cilian Product and Services
2.2.5 Cilian Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aptalis Pharma
2.3.1 Aptalis Pharma Details
2.3.2 Aptalis Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aptalis Pharma SWOT Analysis
2.3.4 Aptalis Pharma Product and Services
2.3.5 Aptalis Pharma Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly SWOT Analysis
2.4.4 Eli Lilly Product and Services
2.4.5 Eli Lilly Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2018-2019)
2.5 Laboratoires Mayoly Spindler
2.5.1 Laboratoires Mayoly Spindler Details
2.5.2 Laboratoires Mayoly Spindler Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Laboratoires Mayoly Spindler SWOT Analysis
2.5.4 Laboratoires Mayoly Spindler Product and Services
2.5.5 Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2018-2019)
2.6 Nordmark Arzneimittel
2.6.1 Nordmark Arzneimittel Details
2.6.2 Nordmark Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Nordmark Arzneimittel SWOT Analysis
2.6.4 Nordmark Arzneimittel Product and Services
2.6.5 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Exocrine Pancreatic Insufficiency Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Exocrine Pancreatic Insufficiency Players Market Share
3.2.2 Top 10 Exocrine Pancreatic Insufficiency Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Exocrine Pancreatic Insufficiency Revenue and Market Share by Regions
4.2 North America Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
4.3 Europe Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
4.5 South America Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
5 North America Exocrine Pancreatic Insufficiency Revenue by Countries
5.1 North America Exocrine Pancreatic Insufficiency Revenue by Countries (2015-2020)
5.2 USA Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
5.3 Canada Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
5.4 Mexico Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
6 Europe Exocrine Pancreatic Insufficiency Revenue by Countries
6.1 Europe Exocrine Pancreatic Insufficiency Revenue by Countries (2015-2020)
6.2 Germany Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
6.3 UK Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
6.4 France Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
6.5 Russia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
6.6 Italy Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Exocrine Pancreatic Insufficiency Revenue by Countries
7.1 Asia-Pacific Exocrine Pancreatic Insufficiency Revenue by Countries (2015-2020)
7.2 China Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
7.3 Japan Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
7.4 Korea Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
7.5 India Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
8 South America Exocrine Pancreatic Insufficiency Revenue by Countries
8.1 South America Exocrine Pancreatic Insufficiency Revenue by Countries (2015-2020)
8.2 Brazil Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
8.3 Argentina Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Exocrine Pancreatic Insufficiency by Countries
9.1 Middle East & Africa Exocrine Pancreatic Insufficiency Revenue by Countries (2015-2020)
9.2 Saudi Arabia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
9.3 UAE Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
9.4 Egypt Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
9.5 South Africa Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Exocrine Pancreatic Insufficiency Revenue and Market Share by Type (2015-2020)
10.2 Global Exocrine Pancreatic Insufficiency Market Forecast by Type (2019-2024)
10.3 Nutritional management Revenue Growth Rate (2015-2025)
10.4 Pancreatic enzyme replacement therapy (PERT) Revenue Growth Rate (2015-2025)
10.5 Life style modifications approach Revenue Growth Rate (2015-2025)
11 Global Exocrine Pancreatic Insufficiency Market Segment by Application
11.1 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Application (2015-2020)
11.2 Exocrine Pancreatic Insufficiency Market Forecast by Application (2019-2024)
11.3 Magnetic resonance imaging (MRI) Revenue Growth (2015-2020)
11.4 CT scanning Revenue Growth (2015-2020)
11.5 Endoscopic ultrasonography (EUS) Revenue Growth (2015-2020)
11.6 Blood tests Revenue Growth (2015-2020)
11.7 Other tests Revenue Growth (2015-2020)
12 Global Exocrine Pancreatic Insufficiency Market Size Forecast (2021-2025)
12.1 Global Exocrine Pancreatic Insufficiency Market Size Forecast (2021-2025)
12.2 Global Exocrine Pancreatic Insufficiency Market Forecast by Regions (2021-2025)
12.3 North America Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
12.4 Europe Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
12.6 South America Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Exocrine Pancreatic Insufficiency Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Exocrine Pancreatic Insufficiency by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Exocrine Pancreatic Insufficiency Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Exocrine Pancreatic Insufficiency Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Axcan Pharma Corporate Information, Location and Competitors
Table 6. Axcan Pharma Exocrine Pancreatic Insufficiency Major Business
Table 7. Axcan Pharma Exocrine Pancreatic Insufficiency Total Revenue (USD Million) (2017-2018)
Table 8. Axcan Pharma SWOT Analysis
Table 9. Axcan Pharma Exocrine Pancreatic Insufficiency Product and Solutions
Table 10. Axcan Pharma Exocrine Pancreatic Insufficiency Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Cilian Corporate Information, Location and Competitors
Table 12. Cilian Exocrine Pancreatic Insufficiency Major Business
Table 13. Cilian Exocrine Pancreatic Insufficiency Total Revenue (USD Million) (2018-2019)
Table 14. Cilian SWOT Analysis
Table 15. Cilian Exocrine Pancreatic Insufficiency Product and Solutions
Table 16. Cilian Exocrine Pancreatic Insufficiency Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Aptalis Pharma Corporate Information, Location and Competitors
Table 18. Aptalis Pharma Exocrine Pancreatic Insufficiency Major Business
Table 19. Aptalis Pharma Exocrine Pancreatic Insufficiency Total Revenue (USD Million) (2017-2018)
Table 20. Aptalis Pharma SWOT Analysis
Table 21. Aptalis Pharma Exocrine Pancreatic Insufficiency Product and Solutions
Table 22. Aptalis Pharma Exocrine Pancreatic Insufficiency Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Eli Lilly Corporate Information, Location and Competitors
Table 24. Eli Lilly Exocrine Pancreatic Insufficiency Major Business
Table 25. Eli Lilly Exocrine Pancreatic Insufficiency Total Revenue (USD Million) (2017-2018)
Table 26. Eli Lilly SWOT Analysis
Table 27. Eli Lilly Exocrine Pancreatic Insufficiency Product and Solutions
Table 28. Eli Lilly Exocrine Pancreatic Insufficiency Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Laboratoires Mayoly Spindler Corporate Information, Location and Competitors
Table 30. Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Major Business
Table 31. Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Total Revenue (USD Million) (2017-2018)
Table 32. Laboratoires Mayoly Spindler SWOT Analysis
Table 33. Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Product and Solutions
Table 34. Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Nordmark Arzneimittel Corporate Information, Location and Competitors
Table 36. Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Major Business
Table 37. Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Total Revenue (USD Million) (2017-2018)
Table 38. Nordmark Arzneimittel SWOT Analysis
Table 39. Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Product and Solutions
Table 40. Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Exocrine Pancreatic Insufficiency Revenue (Million USD) by Players (2015-2020)
Table 42. Global Exocrine Pancreatic Insufficiency Revenue Share by Players (2015-2020)
Table 43. Global Exocrine Pancreatic Insufficiency Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Regions (2015-2020)
Table 45. North America Exocrine Pancreatic Insufficiency Revenue by Countries (2015-2020)
Table 46. North America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2015-2020)
Table 47. Europe Exocrine Pancreatic Insufficiency Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Exocrine Pancreatic Insufficiency Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Exocrine Pancreatic Insufficiency Revenue by Countries (2015-2020)
Table 50. South America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Exocrine Pancreatic Insufficiency Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2015-2020)
Table 53. Global Exocrine Pancreatic Insufficiency Revenue (Million USD) by Type (2015-2020)
Table 54. Global Exocrine Pancreatic Insufficiency Revenue Share by Type (2015-2020)
Table 55. Global Exocrine Pancreatic Insufficiency Revenue Forecast by Type (2021-2025)
Table 56. Global Exocrine Pancreatic Insufficiency Revenue by Application (2015-2020)
Table 57. Global Exocrine Pancreatic Insufficiency Revenue Share by Application (2015-2020)
Table 58. Global Exocrine Pancreatic Insufficiency Revenue Forecast by Application (2021-2025)
Table 59. Global Exocrine Pancreatic Insufficiency Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Exocrine Pancreatic Insufficiency Picture
Figure 2. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Type in 2019
Figure 3. Nutritional management Picture
Figure 4. Pancreatic enzyme replacement therapy (PERT) Picture
Figure 5. Life style modifications approach Picture
Figure 6. Exocrine Pancreatic Insufficiency Revenue Market Share by Application in 2019
Figure 7. Magnetic resonance imaging (MRI) Picture
Figure 8. CT scanning Picture
Figure 9. Endoscopic ultrasonography (EUS) Picture
Figure 10. Blood tests Picture
Figure 11. Other tests Picture
Figure 12. Global Exocrine Pancreatic Insufficiency Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Exocrine Pancreatic Insufficiency Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Exocrine Pancreatic Insufficiency Revenue Market Share in 2019
Figure 21. Global Top 10 Players Exocrine Pancreatic Insufficiency Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Regions (2015-2020)
Figure 25. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Regions in 2018
Figure 26. North America Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 27. Europe Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 29. South America Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 31. North America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2015-2020)
Figure 32. North America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2019
Figure 33. USA Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 34. Canada Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 36. Europe Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2019
Figure 38. Germany Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 39. UK Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 40. France Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 41. Russia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 42. Italy Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2019
Figure 45. China Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 46. Japan Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 47. Korea Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 48. India Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 50. South America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2015-2020)
Figure 51. South America Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2019
Figure 52. Brazil Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Exocrine Pancreatic Insufficiency Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Exocrine Pancreatic Insufficiency Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 57. UAE Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Exocrine Pancreatic Insufficiency Revenue and Growth Rate (2015-2020)
Figure 60. Global Exocrine Pancreatic Insufficiency Revenue Share by Type (2015-2020)
Figure 61. Global Exocrine Pancreatic Insufficiency Revenue Share by Type in 2019
Figure 62. Global Exocrine Pancreatic Insufficiency Market Share Forecast by Type (2021-2025)
Figure 63. Global Nutritional management Revenue Growth Rate (2015-2020)
Figure 64. Global Pancreatic enzyme replacement therapy (PERT) Revenue Growth Rate (2015-2020)
Figure 65. Global Life style modifications approach Revenue Growth Rate (2015-2020)
Figure 66. Global Exocrine Pancreatic Insufficiency Revenue Share by Application (2015-2020)
Figure 67. Global Exocrine Pancreatic Insufficiency Revenue Share by Application in 2019
Figure 68. Global Exocrine Pancreatic Insufficiency Market Share Forecast by Application (2021-2025)
Figure 69. Global Magnetic resonance imaging (MRI) Revenue Growth Rate (2015-2020)
Figure 70. Global CT scanning Revenue Growth Rate (2015-2020)
Figure 71. Global Endoscopic ultrasonography (EUS) Revenue Growth Rate (2015-2020)
Figure 72. Global Blood tests Revenue Growth Rate (2015-2020)
Figure 73. Global Other tests Revenue Growth Rate (2015-2020)
Figure 74. Global Exocrine Pancreatic Insufficiency Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Exocrine Pancreatic Insufficiency Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Exocrine Pancreatic Insufficiency Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
Figure 78. Europe Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
Figure 80. South America Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Exocrine Pancreatic Insufficiency Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
膵臓ステントの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pancreatic Stent market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pancreatic Stent market repo…- 膵臓ベータ細胞保護の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Pancreatic Beta-Cell Protection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pancreatic Be…
- AFPテストの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global AFP Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AFP Testing market report provide…
- アンドロゲン補充療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Androgen Replacement Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Androgen Replace…
- ホスホリパーゼ酵素の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Phospholipase Enzyme market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Phospholipase Enzyme mar…